Atlas Trials

The Safety and Efficacy of NouvSoma001 in Neuromyelitis Optica Spectrum Disorders

Clinical trial NCT06620809 · RECRUITING

Trial details

NCT number
NCT06620809
Sponsor
Tongji Hospital
Status
RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
Neuromyelitis Optica Spectrum Disorders
Start date
2025-03-28
Primary completion
2026-11-30
Enrollment
69

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.